-ML-Based-Comparative-Analysis-of-Abiraterone-and-Enzalutamide-Hormonal-Therapies-for-mCRPC

This project uses machine learning models to compare the effectiveness of abiraterone and enzalutamide therapies for metastatic castration-resistant prostate cancer (mCRPC). By analyzing patient data, it predicts treatment outcomes and provides insights to support personalized therapy decisions.